Summary5 F; @. I% q2 L4 K* p, P0 {
API is a key link in pharmaceutical production and closely related to public health. And the Special API is different from the bulk API, has the characteristics of strong growth attribute, high customer stickiness, non-standard and so on, usually the gross profit rate and the net profit rate are high. Once the enterprise occupies a higher share in the dominant variety market, it can enjoy long-term stable profits. Figure Development Path of Statins API Enterprises Special APIs are components of chemical APIs. Chemical API companies generally produce and sell products independently or according to the needs of downstream customers.Its market is large and its customers are usually pharmaceutical preparation manufacturers, health products manufacturers, feed manufacturers and food manufacturers. Figure Global Chemical API Market Size (US$ Billion) Featured API usually refers to the drug under patent protection or the drug under patent protection. If the enterprise can in innovative drug development stage and the original drug firms through customization methods such as establish relations of cooperation, to provide the clinical trials needed for active pharmaceutical ingredients, then after the product, the enterprise can to provide the original manufacturer pharmaceutical intermediates or APIs, usually can get stable orders, lasting profits for the enterprise. For drugs that have passed the patent period, take the export to the us market as an example, the API manufacturers usually pass the FDA certification before the patent drug expires, apply for the DMF filing, and carry out production capacity reserve. The customers also inform the API manufacturers to prepare the products in time. Generally, after the expiration of patented drugs, a large number of generic drugs will come to market, and drug prices will fall, which will increase the sales volume of generic drugs, and thus drive the demand for API drugs. Figure Global Patents being Expiring The main levels of Statins API are divided into Statins API, Heparin API and others such as Sartans API according to different fields. 2 y1 L5 T3 x+ L N. @4 r% v; A5 Y
Statins, with their high efficiency, safety and tolerability in lowering LDL and cholesterol, are in an unassailable position compared with other lipid-lowering drugs such as niacin and betts, with a market share of up to 90%. 人在德国 社区6 U/ {" m/ b' n; n" a
Heparin API is in the middle of the heparin industry chain.First, the crude heparin sodium was extracted from the small intestinal mucosa of healthy pigs and made into heparin. Due to the impurities such as miscellaneous proteins, it was further purified and turned into heparin API.Heparin APIs are commonly found in the form of Sodium or Calcium salts, known as Heparin Sodium or Heparin Calcium, and are used in excess of standard Heparin Sodium. The major Statins APIs player in the market Company Livzon Pharmaceutical Group Zhejiang Medicine Zhejiang Hisun Pharmaceutical Chongqing Daxin Pharmaceutical Jiangsu Guotai International Group
$ O0 o- \! A# _% y0 ^, b/ i8 B; H
In addition to the mainstream Statins APIs of various manufacturers, each manufacturer also has different models and functions of Heparin API + T' u. G) q) X. S% l1 G% R" W
The major Heparin API player in the market Changzhou Qianhong Biopharma l Shenzhen Hepalink Pharmaceutical Group CSBIO Nanjing King-friend Biochemical Pharmaceutical
3 S" E& E* x+ f' X) h7 MHeparin API belongs to Special API (different from bulk API). Heparin APIs are mainly used in the production of standard heparin preparations or low molecular weight heparin APIs, which can be further used in the production of low molecular weight heparin preparations. Figure Demand for Heparin API from 2007 to 2019  In addition to the companies listed in the above table, Huahai Pharmaceutical, Apeloa Pharmaceutical, Borui Medicine, Jiuzhou Pharmaceutical, Zhejiang Tianyu Pharmaceutical, Zhejiang Xianju Pharmaceutical, Zhejiang Starry Pharmaceutical, Ningbo Menovo Pharmaceutical, Zhejiang Ausun Pharmaceutical, Jiangxi Synergy Pharmaceutical, Jiangxi Fushine Pharmaceutical, developed and manufacture Statins API. Figure Growth Analysis of Major Specialty API Manufacturers According to the statistics of the medical insurance chamber of commerce, in 2018, China exported 929.72 tons of western medicine API (synthesis + fermentation), with a total export value of us $30.048 billion, accounting for about 19% of the global API market. outlines the location of manufacturing facilities used to make APIs for US-marketed drugs. For all regulated drugs (prescription [branded and generics], OTC products, and compounded drugs, the US has 510 manufacturing facilities or 28%, the rest of the world (non-China) 1,048 facilities, or 59%, and China 230 facilities or 13%.
. J! {5 M9 a& H! T
* [; y" H. Z) M2 N3 r/ F" M
With the optimization of statin API production process and the formation of industrial scale in China, the capacity and output of statin API have been objectively promoted.With COVID-19 spreading globally, Europe and the United States have suffered a major impact.Meanwhile , COVID-19 affectmajor API suppliers such as India, China and Japan. 
On March 24, India announced the start of a nationwide lockdown for 21 days as a precaution against COVID 19. But when India announced its decision, the global drug industry was not calm - after all, India is the world's largest producer of generic drugs, the 13th largest exporter by value and the third largest exporter by volume, which is crucial to the world's drug supply. 8 q* l2 V+ ^% V. t9 N/ Q$ T. H6 P& I, B
k/ l% C) j! v8 n: o% `' ^
Under the influence of the global COVID 19 epidemic, China's API products ushered in a wave of price rise tide.
# B2 U' t9 z. T% V; o' T7 ^+ ^
Vitamin, March 25, VD3 quoted US$ 35.25 /kg, compared to the beginning of the year (January 20, 2020) increase 170%;VB1 quoted US$42 yuan/kg, up 90% from the beginning of the year; Biotin quoted US$43 /kg, up 74% from the beginning of the year; The quotation of VA is US$71.2 /kg, which is 64% higher than that of the beginning of the year. Vitamin K3 quoted US$13 /kg, 59% higher than the beginning of the year;VE quoted US$10.22/kg, up 49% from the beginning of the year. Figure Price/Gross Margin Analysis In terms of antibiotics, under the influence of the epidemic, the supply side is gradually tight, and the price of major varieties has also shown a trend of increasing, especially the intermediate varieties with oligopoly pattern, such as 6-apa, whose market price recently increased from 20.0 US$ to 28.7 US$ per kg. 5 c, k3 g0 K2 |( K& w* C
QY Research has recently curated a research report titled, Global Specialty Active Pharmaceutical Ingredients Market Research Report 2020. The report is structured on primary and secondary research methodologies that derive historic and forecast data. The global Specialty Active Pharmaceutical Ingredients market is growing remarkably fast and is likely to thrive in terms of volume and revenue during the forecast period. Readers can gain insight into the various opportunities and restraints shaping the market. The report demonstrates the progress and bends that will occur during the forecast period. Global Specialty Active Pharmaceutical Ingredients Market: Drivers and Restrains The research report has incorporated the analysis of different factors that augment the market’s growth. It constitutes trends, restraints, and drivers that transform the market in either a positive or negative manner. This section also provides the scope of different segments and applications that can potentially influence the market in the future. The detailed information is based on current trends and historic milestones. This section also provides an analysis of the volume of sales about the global market and also about each type from 2015 to 2026. This section mentions the volume of sales by region from 2015 to 2026. Pricing analysis is included in the report according to each type from the year 2015 to 2026, manufacturer from 2015 to 2020, region from 2015 to 2020, and global price from 2015 to 2026. A thorough evaluation of the restrains included in the report portrays the contrast to drivers and gives room for strategic planning. Factors that overshadow the market growth are pivotal as they can be understood to devise different bends for getting hold of the lucrative opportunities that are present in the ever-growing market. Additionally, insights into market expert’s opinions have been taken to understand the market better. Global Specialty Active Pharmaceutical Ingredients Market: Segment Analysis The research report includes specific segments such as application and product type. Each type provides information about the sales during the forecast period of 2015 to 2026. The application segment also provides revenue by volume and sales during the forecast period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Global Specialty Active Pharmaceutical Ingredients Market: Regional Analysis The research report includes a detailed study of regions of North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The report has been curated after observing and studying various factors that determine regional growth such as economic, environmental, social, technological, and political status of the particular region. Analysts have studied the data of revenue, sales, and manufacturers of each region. This section analyses region-wise revenue and volume for the forecast period of 2015 to 2026. These analyses will help the reader to understand the potential worth of investment in a particular region. Global Specialty Active Pharmaceutical Ingredients Market: Competitive Landscape This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019. Following are the segments covered by the report are: Steroidal API Peptide API Carbohydrate API Small Molecule API High Potency AP By Application: CNS Cardiovascular Genitourinary/Hormonal Drugs Rheumatology Diabetes Oncology Others Key Players: The Key manufacturers that are operating in the global Specialty Active Pharmaceutical Ingredients market are: Sanofi Cambrex Almac Johnson Matthey PolyPeptide AmbioPharm Avecia ST Pharm Biospring Competitive Landscape The analysts have provided a comprehensive analysis of the competitive landscape of the global Specialty Active Pharmaceutical Ingredients market with the company market structure and market share analysis of the top players. The innovative trends and developments, mergers and acquisitions, product portfolio, and new product innovation to provide a dashboard view of the market, ultimately providing the readers accurate measure of the current market developments, business strategies, and key financials. | 
发表于 2020-4-2 07:29
| 
